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G E N E T I C S
DNA methylation at a nutritionally sensitive region 
of the PAX8 gene is associated with thyroid volume 
and function in Gambian children
Toby Candler1, Noah Kessler2, Chathura Gunasekara3, Kate Ward1,4, Philip James5, 
Eleonora Laritsky3, Maria Baker3, Roger Dyer6, Rajavel Elango6, David Jeffries1, 
Robert Waterland3,7, Sophie Moore1,8, Marian Ludgate9, Andrew Prentice1, Matt Silver1*
PAX8 is a key thyroid transcription factor implicated in thyroid gland differentiation and function, and PAX8 gene 
methylation is reported to be sensitive to the periconceptional environment. Using a novel recall-by-epigenotype 
study in Gambian children, we found that PAX8 hypomethylation at age 2 years is associated with a 21% increase 
in thyroid volume and an increase in free thyroxine (T4) at 5 to 8 years, the latter equivalent to 8.4% of the normal 
range. Free T4 was associated with a decrease in DXA-derived body fat and bone mineral density. Furthermore, 
offspring PAX8 methylation was associated with periconceptional maternal nutrition, and methylation variability 
was influenced by genotype, suggesting that sensitivity to environmental exposures may be under partial genetic 
control. Together, our results demonstrate a possible link between early environment, PAX8 gene methylation 
and thyroid gland development and function, with potential implications for early embryonic programming of 
thyroid-related health and disease.
INTRODUCTION
Thyroid hormones regulate a wide range of physiological processes 
and influence various outcomes related to cognition, growth, skele-
tal, cardiovascular, and metabolic health (1). While clinical sequelae 
of severe perturbations of thyroid hormone production are well 
documented (2), variation of thyroid function within the normal 
population reference range is also associated with a range of pheno-
typic traits including blood pressure, lipids, obesity, cardiovascular 
mortality, bone mineral density (BMD), and cancer risk (3).
The function of the hypothalamic-pituitary-thyroid axis is clinically 
assessed by measurement of pituitary-derived thyrotropin (TSH), 
free T4 (free thyroxine), and free T3 (free tri-iodothyronine). Higher 
TSH and lower free T4 are associated with adverse pregnancy out-
comes (3) and increased body mass index (BMI) in adults (4) and 
children (5). Lower TSH and higher free T4 are associated with an 
increased risk of osteoporosis and fracture (3), and levels of free T4 
are correlated with the concentration of various lipoproteins (6).
Heritability of thyroid function has been reported to be between 
32 and 65% (free T4), 23 and 67% (free T3), and 32 and 65% (TSH) 
(7). However, current identified genetic variants associated with 
thyroid function contribute only a small amount to interindividual 
variation in thyroid hormone concentrations. For example, although 
a recent genome-wide association study (GWAS) identified 74 loci 
associated with TSH, together these explained just 13.3% of TSH 
variance, leaving much of the reported heritability unexplained (8). 
Moreover, congenital hypothyroidism (CHT), the most common 
endocrinopathy of childhood, is generally not inherited [less than 
5% of cases have an identifiable genetic cause (9)] with 98% of cases 
nonfamilial (10) and a high discordance rate (92%) in monozygotic 
twins (11). In addition, seasonal variation in CHT incidence has 
been reported in the United Kingdom and Japan (12, 13), and a recent 
study reported that prenatal famine exposure has been associated 
with higher TSH in adulthood (14). Together, these observations suggest 
that environmental factors and epigenetic or unknown genetic mecha-
nisms may play a role in thyroid development and/or function.
PAX8 (paired-box 8) protein is one of four known thyroid tran-
scription factors (TTFs) essential for thyroid development and func-
tion [others include NK2 homeobox 1 (NKX2-1), forkhead box E1 
(FOXE1), and hematopoietically expressed homeobox (HHEX)] (15). 
These transcription factors regulate expression of thyroid-specific 
genes related to thyroid hormone production and storage such as 
TPO (thyroid peroxidase), Tg (thyroglobulin), and the sodium-iodide 
symporter (15, 16) and are important for development and differ-
entiation of the thyroid gland (17). PAX8 has been described as the 
“master regulator,” with a role in regulating the activity of other 
TTFs (16). PAX8 knockout mice demonstrate that thyroid hypoplasia, 
low birth weight and growth retardation (18), and genetic mutations 
in PAX8 can cause CHT in humans (19).
Epigenetic processes, including DNA methylation, histone modi-
fication, protein binding of DNA, chromatin remodeling, and RNA- 
based mechanisms, can affect gene expression (20). DNA methylation 
at CpG “islands” [cytosine (C) and guanine (G) separated by phos-
phate (p)] within promoter regions may regulate gene transcription in 
a tissue-specific manner (21). Promoter DNA methylation is usually 
associated with condensed heterochromatin and transcriptional down- 
regulation (22). Metastable epialleles (MEs) are epigenetic loci that 
demonstrate systemic (i.e., not tissue-specific) methylation with sub-
stantial variation between individuals (23). The methylation patterns 
are thought to be established early in embryonic development (24) 
and are not driven by genetic variation (23, 24). Methylation at MEs 
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is influenced by maternal diet around conception (25–29), and puta-
tive human MEs with stable methylation levels have been linked to 
disease-related phenotypes (25, 26). These characteristics position MEs 
as potential epigenetic mediators of the effect of early environmental 
exposures in the developmental origins of health and disease (30).
The PAX8 gene contains a putative human ME with evidence of 
systemic interindividual variation (23,  25,  31) and sensitivity to 
periconceptional and prenatal environment (see table S1). There is 
evidence that PAX8 promoter methylation patterns in leucocytes 
and thyroid are concordant in children (32). Data from The 
Gambia showed that leucocyte PAX8 methylation was higher in 
children conceived in the annual rainy (or “hungry”) season 
(25, 31). In Bangladesh, higher methylation at the PAX8 gene was 
reported in offspring following gestational famine exposure (27). A 
set of interlocking pathways, collectively known as one-carbon 
metabolism, provides methyl groups for DNA methylation and is 
dependent on multiple nutritional factors that act as substrates and 
essential cofactors (33). Seasonally driven variations in maternal 
circulating levels of one-carbon metabolites have been reported in 
The Gambia (34). Maternal supplementation with folic acid (a syn-
thetic source of folate and a one-carbon metabolite) has been asso-
ciated with differential PAX8 methylation in adult offspring (35), 
and maternal preconception multiple micronutrient (MMN) sup-
plementation was associated with differential methylation at PAX8 
in Gambian children (36).
Epigenetic influence on thyroid function or development has 
been little explored. Considering its key roles in thyroid develop-
ment and regulation of the mature thyroid gland, and its epigenetic 
sensitivity to the early environment, PAX8 is a prime candidate for 
study. Using a recall-by-epigenotype design, we examined links 
between PAX8 DNA methylation measured at 2 years of age in pe-
ripheral blood and thyroid gland function and development in the 
same Gambian children aged 5 to 8 years. In addition, by examining 
body composition and BMD using dual energy x-ray absorptiometry 
(DXA) scans, we explored how PAX8 methylation (via its putative 
effect on thyroid hormone production) may influence measures of 
adiposity and BMD. Using maternal biomarker data (including 
measures of one-carbon metabolites), we also explored how a child’s 
PAX8 methylation status may be influenced by their mother’s 
nutritional status around the time of conception and assessed the 
influence of genetic variation in cis. Last, using data from The Cancer 
Genome Atlas (TCGA), we investigated the relationship between PAX8 
methylation and gene expression in thyroid tissue and assessed cor-
relations between thyroid and whole blood methylation in samples 
from the Genotype-Tissue Expression (GTEx) Project.
RESULTS
PAX8 region of interest, participant selection, and  
baseline characteristics
Children from the “ENID” (Early Nutrition and Immune Development) 
trial (37) now aged between 5 and 8 years (n = 493) were recruited 
into “high” and “low” groups, according to their DNA methylation 
status in peripheral blood at age 2 years at a region of the PAX8 gene 
(see Figs. 1 to 3). This region was selected on the basis of evidence of 
systemic interindividual variation and sensitivity to early environ-
ment from previous studies (23,  25,  31). DNA methylation was 
measured at four CpGs, which were highly correlated with adjacent 
CpGs and had sufficient coverage (see Materials and Methods and 
fig. S10 for further details).
One hundred eighteen children were recruited [high PAX8 
methylation group n = 58 (mean methylation (SD) = 0.96 (0.036)] 
and low PAX8 methylation group n = 60 [0.50 (0.088)] with a median 
age [interquartile range (IQR)] of 7.18 years (1.67). Children in the 
low PAX8 methylation group had a significantly lower BMI z score, 
but there were no significant differences in age, sex, weight-for-age 
z score (WAZ), height-for-age z score (HAZ), or pregnancy and infant 
supplementation received between the two groups (see Table 1).
Associations between PAX8 methylation and thyroid outcomes
Thyroid volume
Thyroid ultrasound scans were performed blinded to PAX8 methyl-
ation group on 114 children (four children did not attend for scans). 
Of these, two had technical difficulties in ascertaining accurate mea-
surements and were removed from subsequent analysis (both were 
in the high methylation group). A single case of right thyroid lobe 
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hemiagenesis in the high PAX8 methylation group was the only ab-
normality identified. This participant was retained in the analysis as 
total thyroid volume was within normal range.
In crude unadjusted analyses, total thyroid volume was elevated 
in the low methylation group (3.24 versus 2.87 cm3 in the high PAX8 
methylation group, P = 0.035; see Table 2). In a multiple linear re-
gression model adjusting for age, sex, BMI, and urinary iodine con-
centration (UIC), the association between PAX8 methylation group 
and total thyroid volume was strengthened, yielding a 0.61 cm3 
[SE = 0.15] or 21% higher thyroid volume in the low versus high 
group (P = 0.0001; see Table 3). This analysis also revealed signifi-
cant associations between total thyroid volume and age, sex, BMI, 
and UIC (see table S2).
Thyroid function
In crude comparisons of thyroid function measures (free T4, free 
T3, TSH, and Tg) between the two groups, free T4 was observed to 
be significantly lower in the high PAX8 methylation group (13.3 
versus 13.9 pM, P = 0.009; see Table 2).
Iodine insufficiency was evaluated by two methods: plasma Tg 
level and UIC. On the basis of Tg level, there was no difference in 
iodine insufficiency between the groups, but significantly more children 
were classified with iodine insufficiency by UIC in the high PAX8 
methylation group compared to the low PAX8 methylation group 
[21 of 56 (37.5%) versus 10 of 60 (16.7%), P = 0.02], and UIC was 
also higher in the low PAX8 methylation group (170 versus 128 g/
liter, P = 0.04; see table S3). Since iodine concentration and/or 
insufficiency can affect thyroid function, UIC was included as an 
adjustment covariate in regression models to ensure appropriate 
adjustment was made for these group differences.
In a multiple linear regression model with adjustment for age, 
sex, and UIC, free T4 level was 0.85 pM [SE = 0.24] higher in the low 
PAX8 methylation group (P = 0.0007; see Table 3 and table S4). The 
laboratory normal range for free T4 is between 9.0 and 19.1 pM, so 
this difference between the two groups—8.4% of the normal range—
is substantial. No significant associations between PAX8 methylation 
and TSH, free T3, or Tg were observed after adjustment for age, sex, 
and UIC (see Table 3 and table S4).
Association between free T4 and body composition and 
bone mineral outcomes
We hypothesized that PAX8 methylation (via its putative effect on 
thyroid hormone production) may influence measures of adiposity 
and BMD. To explore potential associations between free T4 and fat 
mass index (FMI), lean mass index (LMI), and BMD, whole-body 
DXA scans were performed on 113 of the 5- to 8-year-old children.
In multiple regression models adjusted for relevant covariates, 
log FMI was associated with free T4 ( = −0.04 [SE 0.02], P = 0.033; 
see Table 4 and table S5), so that for every picomolar increase in free 
T4, there was a 4.3% reduction in FMI. Free T4 was not associated 
with LMI (see table S6). Free T4 was inversely associated with log 
total-body-less-head (TBLH) BMD ( = −0.008 [0.004], P = 0.044), 
so that TBLH BMD was reduced by 0.8% for every picomolar in-
crease in free T4 (see Table 4 and table S7).
Causal mediation analysis
Since we demonstrated significant associations between PAX8 methyl-
ation group and both thyroid volume and free T4, we postulated that 
the methylation state set early in embryonic development (which we 
measured at the age of 2) could influence thyroid development and 
volume via regulation of PAX8 expression and that this change in 
thyroid volume could in turn affect thyroid function and free T4 
measured at 5 to 7 years of age. We therefore conducted a causal 
mediation analysis to test this, but this provided no evidence that the 
effect of differential methylation at PAX8 on thyroid function was 
mediated by thyroid volume [average causal mediation effect (ACME) 
or mediated effect = 0.031, 95% confidence interval −0.15 to 0.22, 
P = 0.74; see fig. S1]. As  we did not find any evidence of a significant 
effect of PAX8 methyl ation group on either BMD or any fat measure, 
we did not perform causal mediation analysis for these pathways.
Predictors of PAX8 methylation
We performed an analysis of the potential influence of sex and child 
and maternal BMI on PAX8 methylation in n = 521 ENID-recruited 
children with 2-year PAX8 methylation measurements (i.e., not re-
stricted to the n = 118 high and low methylation groups analyzed 
above). In simple linear regression models, sex was significantly 








Fig. 2. PAX8 region of interest. The PAX8 gene extends from chr2:113,215,997 to 
113,278,921 (hg38) and contains 12 exons and 11 introns. Exons 8 and 9 of PAX8 
are shown, as well as the first two exons of an isoform of the PAX8-AS1 antisense 
long noncoding RNA. CpGs are shown in the top track. The four CpGs highlighted 
in red were analyzed in this study (chr2:113,235,186; 113,235,228; 113,235,251; and 
113,235,267). The “Known DMRs” (differentially methylated regions) track highlights 
regions identified in the following studies: putative MEs displaying systemic inter-
individual variation identified in (i) Silver et al. (25) and (ii) Kessler et al. (23); (iii) DMR 
associated with gestational famine (27), Gambian SoC (35), and maternal folic acid 
supplementation (35); and (iv) DMRs associated with Gambian SoC in an additional 
study (31). The SNP track denotes variants within 2000 bp of the CpGs of interest 
that were called from the methyl-seq data. The SNP highlighted in red is close to 
our region of interest and tags an LD block encompassing it (see fig. S11). This is 
the SNP used for the genotype analyses (rs10193733; chr2:113,235,047 T > C).
Fig. 3. DNA methylation in the study population at the PAX8 CpGs of interest. 
Individuals were sorted by methylation level at CpG chr2:113,235,228 (indicated by 
dots), which was used to select the high (red) and low (blue) PAX8 methylation groups. 
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associated with PAX8 methylation, with males having 0.24 [SE  = 
0.09] lower mean logit methylation compared to females (P = 0.005; 
see fig. S2 for comparison of equivalent untransformed mean % 
methylation difference). There were no significant associations 
between PAX8 methylation and child BMI z score (  =  −0.02 
[SE = 0.04], P = 0.64), maternal BMI ( = 0.0004 [0.01], P = 0.98), 
infant WAZ ( = −0.05 [0.05], P = 0.27), or season of conception 
(SoC) ( = 0.09 [0.09], P = 0.29).
Table 1. Baseline characteristics between high and low PAX8 methylation groups. Group differences in normally distributed variables (WAZ, HAZ, and BMI) 
assessed by Student’s t test, nonnormally distributed variables (age) by Mann-Whitney U test, and categorical variables (sex and ENID supplementation group) 
by chi-square test. WAZ, weight-for-age z score; HAZ, height-for-age z score; PE, protein energy supplementation; FeFol, iron and folate supplementation; MMN, 
multiple micronutrient supplementation. 
All (n = 118) High PAX8 methylation (n = 58)
Low PAX8 methylation 
(n = 60) P value
Sex
Male 71 30 41
0.10
Female 47 28 19
Age (years)
Median [IQR] 7.18 [1.67] 7.28 [1.49] 7.09 [1.61] 0.29
Range 5.22 to 8.71 5.22 to 8.68 5.23 to 8.71
Body size measures*
Birth weight (kg) [SD] 3.03 [0.43] 3.01 [0.46] 3.05[0.41] 0.62
Mean WAZ [SD] −1.25 [0.85] −1.18 [0.87] −1.32 [0.82] 0.36
Mean HAZ [SD] −0.75 [0.83] −0.81 [0.86] −0.70 [0.79] 0.43
Mean BMI z score [SD] −1.20 [0.87] −1.01 [0.87] −1.38 [0.84] 0.02
ENID pregnancy supplementation
PE 31 16 15
0.90
FeFol 28 12 16
MMN 26 13 13
PE and MMN 33 17 16
ENID infant supplementation
MMN 54 27 27 1.00
No MMN 64 31 33
*Body size measures reported were measured at recruitment for this current study (i.e., between 5 and 8 years of age).
Table 2. Thyroid volume and function comparison by PAX8 methylation group; crude (unadjusted) analyses. Group differences in normally distributed 
variables (thyroid volume, free T4, and free T3) were assessed by Student’s t test and nonnormally distributed variables (TSH and Tg) by Mann-Whitney U test. 
All High PAX8 methylation Low PAX8 methylation P value
Thyroid volume
Mean total thyroid volume 
[SD] cm3
3.06 [0.93] 2.87 [0.83] 3.24 [0.98]
0.035
n = 112 n = 53 n = 59
Thyroid function
Mean free T4 [SD], pM
13.6 [1.34] 13.3 [1.33] 13.9 [1.29]
0.009
n = 114 n = 55 n = 59
Mean free T3 [SD], pM
6.09 [0.68] 6.08 [0.63] 6.09 [0.74]
0.92
n = 114 n = 55 n = 59
Median TSH [IQR], mU/liter
1.82 [1.01] 1.86[0.92] 1.73 [1.08]
0.34
n = 116 n = 56 n = 60
Median Tg [IQR], g/liter
19.2 [10.70] 18.5 [7.80] 19.4 [15.1] 0.46
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Three hundred three of the 521 children with PAX8 methylation 
data also had paired maternal biomarker data. In multiple linear 
regression models adjusted for sex, four one-carbon metabolites 
were associated with a decrease in PAX8 methylation (see Table 5): 
homocysteine (standardized  = −0.11 [0.05], P = 0.048), cysteine 
( = −0.16 [0.05], P = 0.003), vitamin B12 ( = −0.1 [0.05], P = 0.05), 
and vitamin B6/pyridoxal-5′-phosphate (PLP, a vitamin B6 vitamer) 
( = −0.12 [0.06], P = 0.03).
We also tested an extended panel of maternal biomarkers including 
amino acid levels (see table S8). Two of these biomarkers were asso-
ciated with an increase in PAX8 methylation: uracil (standardized 
 = 0.21 [0.05], P = 0.0001) and arginine ( = 0.16 [0.06], P = 0.006). 
Valine was associated with a decrease in PAX8 methylation ( = −0.13 
[0.05], P = 0.02).
PAX8 methylation, gene expression, and  
methylation tissue concordance
We next investigated the relationship between PAX8 methylation 
and gene expression in thyroid tissue by using data from TCGA. TCGA 
provides gene expression and DNA methylation data on a variety of 
noncancerous tissues including 50 thyroid samples. The methylation 
data are derived from the Illumina HM450 array, which includes 
two of the PAX8 CpGs of interest in this study. Since this region 
overlaps transcripts from sense (PAX8) and antisense (PAX8-AS1) 
genes, we considered the expression of both genes. Using fragments 
per kilobase per million mapped reads (FPKM) as an expression 
metric, PAX8 and PAX8-AS1 expression were positively correlated 
(Spearman R = 0.477, P = 0.0006; see fig. S3, left), but we found only 
weak evidence of an inverse relationship between PAX8 methyl ation 
and PAX8-AS1 or PAX8 expression (see fig. S4, top). However, with 
RNA sequencing by expectation maximization (RSEM) as the metric 
of gene expression, we found strong evidence that PAX8 methyl-
ation was negatively correlated with PAX8-AS1 expression (Spearman 
R = −0.70, P = 6 × 10−8; see fig. S4, bottom right), although there was 
no correlation between PAX8 and PAX8-AS1 expression (fig. S3, right). 
There was no association between PAX8 methylation and expres-
sion using RSEM (fig. S4, bottom left).
We analyzed mean DNA methylation across the four CpGs of 
interest in paired peripheral blood cell and thyroid tissue from 86 
adult samples from the GTEx Project (38) and found no correlation 
(see fig. S5). Public GTEx expression data from 54 tissues shows that 
both PAX8 and PAX8-AS1 are predominantly expressed in thyroid 
(see fig. S6). Note that, in both the TGCA and GTEx dataset, thyroid 
methylation levels of the PAX8 region of interest fall only within the 
high methylation group from our Gambian analysis in peripheral 
blood. Together, our interpretation is that although individual vari-
ation in PAX8 methylation in the early embryo may affect thyroid 
development, at some stage of thyroid development, this region be-
comes uniformly highly methylated in thyroid of all individuals.
Stability of PAX8 methylation from 7 to 17 years of age
We measured PAX8 methylation in 49 Gambian children from stored 
peripheral blood DNA taken at age 7 and 17 years by pyrosequencing. 
Methylation was highly correlated between the two age groups 
(R  =  0.76, P  <  2.2 × 10−16; see fig. S7), indicating that blood cell 
methylation at this locus is highly stable across this age range.
Exploring the relationship between PAX8 methylation, 
genotype, and thyroid function
We focused on a single-nucleotide polymorphism (SNP) (rs10193733) 
proximal to our PAX8 region of interest for genetic analyses (see 
Fig. 2 and Materials and Methods for rationale for selecting this SNP). 
We observed higher methylation for homozygotes for the alternate 
allele (C/C, mean methylation = 0.97) compared to heterozygotes 
(T/C = 0.82 or wild-type alleles (T/T = 0.66; see Fig. 4). However, 
the most notable was that homozygotes for the alternate allele had a 
markedly limited methylation range (C/C, range = 0.93 to 1.00) com-
pared to heterozygotes (C/T, range = 0.50 to 0.99) or homozygotes 
for the reference allele (T/T, range = 0.18 to 1.00; see Fig. 4).
This led us to postulate that the genotype with the greatest vari-
ability (T/T) could be more sensitive to periconceptional environment, 
Table 3. PAX8 methylation group as a predictor of thyroid volume 
and function; multiple linear regression (adjusted) analyses. Low 
PAX8 methylation group coefficient gives the mean increase (decrease if 
negative) relative to the high PAX8 methylation group. Adjustment 
covariates for the multiple linear regression model for total thyroid 
volume are age, sex, BMI, urinary iodine (see table S2). Adjustment 
covariates for multiple linear regression model for free T4, free T3, logTSH, 
and logTg are age, sex, and urinary iodine (see table S3). 







Volume (cm3) 112 0.61 [0.15] 0.0001
Free T4 (pM) 113 0.85 [0.24] 0.0007
Free T3 (pM) 113 −0.02 [0.13] 0.88
Log TSH (mU/
liter) 115 −0.11 [0.09] 0.26
Log Tg (g/liter) 94 0.02 [0.12] 0.85
Table 4. Free T4 as a predictor of FMI and BMD; multiple linear 
regression (adjusted) analyses. Adjustment covariates for the multiple 
linear regression model for logFMI are age, sex, and weight (see table S4). 
Adjustment covariates for multiple linear regression models for log TBLH 
BMD and log TBLH BMC are age, sex, height, and weight (see table S6). 
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offering a potential explanation for the lack of evidence for a SoC 
effect at this locus. Methylation distributions stratified by genotype 
suggested a potential interaction between SoC and genotype (see 
fig. S8), although this was not statistically significant, possibly due 
to a lack of power. We also found no evidence for an interaction 
between maternal nutritional biomarkers and genotype.
We next assessed the direct effect of rs10193733 genotype on 
free T4 and total thyroid volume in multiple linear regression mod-
els with free T4 and total thyroid volume as the dependent variables 
regressed against the number of rs10193733 C alleles and adjusted 
for age, sex, and UIC. The C allele had a significant effect on both 
free T4 ( (per C allele) = −0.61 [SE = 0.16], P = 0.0002) and thyroid 
volume [ (per C allele) = −0.25 [0.11], P = 0.02]. As expected, (see 
Figs. 3 and 4), rs10193733 genotype was also significantly associated 
with PAX8 methylation group (chi-square test P  =  4.24 × 10−13). 
However, the effect of PAX8 methylation group on thyroid volume 
and free T4 did not appear to be purely driven by genotype, as T/C 
and T/T individuals were well represented in both the high and low 
PAX8 methylation groups (see fig. S9).
DISCUSSION
Previous studies in The Gambia and elsewhere have shown a con-
sistent association between DNA methylation at a genomic region 
in the PAX8 gene and the maternal periconceptional environment 
(25, 27, 29, 31). Here, we have demonstrated an association between 
PAX8 methylation and thyroid function in Gambian children, spe-
cifically free T4 and thyroid volume, with a relatively large effect 
size. Thyroid volume differed by >20% between low and high PAX8 
methylation groups after adjusting for covariates. Free T4 demon-
strated a difference of 0.85  pM between groups or 8.4% of the 
normal range.
A recent GWAS of thyroid function found four SNPs [with minor 
allele frequency (MAF) > 1%] associated with free T4. The largest 
reported SNP effect was 0.22 pM per variant allele, and overall, 
common genetic variants together explained just more than 20% of 
the variance in free T4 (39). The difference in free T4 between high 
and low PAX8 methyl ation groups in our study is therefore much 
greater than the largest individual genetic effect previously observed 
(0.85 versus 0.22 pM). Similarly, a recent GWAS found four variants 
associated with thyroid volume explaining just more than 3% of 
thyroid volume variance (40). Here, the largest SNP effect size was 
0.093 cm3 per allele, again far smaller than the effect size seen in our 
study (0.61 cm3 after adjustment for covariates).
Few studies have analyzed associations between DNA methyl-
ation and thyroid function. A recent epigenome-wide association 
study (EWAS) did not find any associations with free T4 but did 
identify two differentially methylated positions (DMPs) associated 
with TSH and six DMPs associated with free T3 (41). There were no 
DMPs from the PAX8 gene associated with thyroid function in this 
EWAS, although the study analyzed data from older European children 
(aged 14 to 17 years), and they may not have analyzed CpGs from 
our region of interest that has limited coverage on the Illumina 
HM450k array used in the study.
Our previous work in The Gambia demonstrated that PAX8 
methylation is sensitive to the periconceptional environment, with 
rainy season conceptions having higher methylation compared to 
conceptions in the dry season (25, 31). There is evidence to suggest 
that the prenatal window where environmental exposures could in-
fluence PAX8 gene methylation may not be limited to the pericon-
ceptional period. Famine exposure (for at least 7 months prenatally) 
(27) and pregnancy folic acid supplementation (35) have been asso-
ciated with PAX8 gene methylation in offspring. We did not find a 
significant SoC effect in this cohort. Our CpGs of interest only par-
tially overlap the SoC-sensitive PAX8 differentially methylated re-
gion highlighted by Silver et al. (25), and they are adjacent to (but 
do not include) the SoC-sensitive region reported by Waterland et al. 
(31). Thus, while they are correlated with regions previously iden-
tified as being sensitive to SoC effects (see fig. S10), the PAX8 CpGs 
in this study were different and may be less sensitive to SoC effects. 
In addition, seasonal effects vary from year to year [see figure S12 
by Waterland et al. (31)], so that it is possible that there may have 
been a diminished seasonal effect during the period of ENID trial 
recruitment compared to previous years. However, we did find 
Table 5. Maternal one-carbon metabolite biomarkers as predictors of PAX8 Methylation. Multiple linear regression models have PAX8 mean logit 
methylation z score as the dependent variable with maternal one-carbon metabolites measured in maternal plasma and back-extrapolated to the time of 
conception as predictors, adjusted for sex. Hcy, homocysteine; DMG, dimethylglycine; PLP, pyridoxal 5-phosphate (B6 vitamer). 
Covariate Standardized coefficient SE t value P value
Hcy (M) −0.11 0.05 −1.99 0.048
Methionine (M) −0.01 0.06 −0.13 0.89
Cysteine (M) −0.16 0.05 −2.95 0.003
Choline (M) −0.01 0.06 −0.20 0.84
Betaine (M) −0.07 0.05 −1.29 0.20
DMG (M) −0.03 0.06 0.52 0.61
B12 (pM) −0.10 0.05 −1.96 0.050
Folate (nM) −0.07 0.05 −1.37 0.17
PLP (nM) −0.12 0.06 −2.17 0.031










Candler et al., Sci. Adv. 7, eabj1561 (2021)     5 November 2021
S C I E N C E  A D V A N C E S  |  R E S E A R C H  A R T I C L E
7 of 14
associations with circulating levels of several one-carbon metabolites 
and amino acids measured in maternal plasma and back-extrapolated 
to the time of conception, and these have previously been shown to 
vary seasonally in this population (34). One-carbon metabolites co-
vary through complex interactions so that, as previously, we have 
presented their nominal associations, unadjusted for multiple com-
parisons (26, 33, 42).
There is evidence that the PAX8 region of interest is an ME 
(23, 25, 27), and circulating levels of one-carbon metabolites at the 
time of conception have previously been associated with offspring 
DNA methylation at several MEs in our population (25, 26, 33). In 
our study, increased cysteine, homocysteine, and PLP (a B6 vitamer) 
were associated with lower DNA methylation at the PAX8 region of 
interest, as previously observed at other MEs (29, 42). Furthermore, 
we identified the amino acids arginine and valine as potential pre-
dictors of PAX8 methylation in a wider panel of periconceptional 
amino acid data. Amino acids and one-carbon metabolites are 
bidirectionally linked: Amino acids can supply cells with one-carbon 
metabolites (43), and levels of one-carbon metabolites can influence 
amino acid metabolism (44).
We observed a strong effect of genotype on DNA methylation 
variability, raising the possibility of a genotype-early environment 
interaction effect on methylation, as has been observed in a number 
of studies (45, 46). We did not find evidence for a genotype-SoC 
interaction at the PAX8 region studied, although we may have had 
limited power to detect this. We noted the presence of an indel 
polymorphism within the PAX8 variably methylated region and in 
very strong linkage disequilibrium (LD) with the cis-SNP associated 
with PAX8 methylation variability. It is plausible that this polymorphism 
influences the binding of a protein that affects methylation variability. 
Future work should explore this and other mechanisms underpin-
ning the strong variability effect that we observed and its potential 
link to differential sensitivity to environmental factors.
In this study, PAX8 methylation was measured at 2 years of age 
in peripheral blood, with phenotypic measures of thyroid function 
measured at 5 to 8 years. There is evidence that methylation in this 
region is systemic, with similar methylation patterns across tissues 
derived from endoderm, ectoderm, and mesoderm lineages, suggesting 
that methylation is established before gastrulation (23, 29, 31, 47). 
We therefore speculate that thyroid PAX8 methylation, influenced 
by environmental factors and established early in gestation, sets a 
trajectory for thyroid gland development that is reflected in differential 
thyroid morphology and function in mid-childhood (see Fig. 5).
PAX8 is expressed early in embryological development [from 
days 20 to 22 in humans (15)]. Therefore, methylation patterns es-
tablished in the cleavage-stage embryo could influence PAX8 gene 
expression from the beginning of thyroid growth and development. 
Furthermore, methylation-driven differential PAX8 expression in 
the differentiated gland could explain the difference in free T4 between 
the groups if high PAX8 methylation down-regulates thyroid-specific 
genes associated with free T4 production. Further work is required 
to elucidate the cellular and molecular mechanisms underpinning 
these relationships.
Although our finding that this region is highly methylated in 
adult thyroid tissue from GTEx and TCGA appears to contradict 
this model, it is possible that thyroid methylation follows the sys-
temic pattern in gestation and early life, followed by aging-associated 
hypermethylation specifically in thyroid. This is consistent with a 
previous study in children that compared DNA methylation in the 
PAX8 promoter between leucocytes and thyroid tissue and found 
them to be correlated (32). A similar lineage-specific effect was ob-
served at the murine AxinFused ME (48).
Our work also highlights a potential epigenetic contribution to 
thyroid gland development that has implications for understanding 
the etiology of nonheritable thyroid pathologies such as CHT. CHT 
is one of the top treatable causes of neurodevelopmental delay and 
is the commonest endocrinopathy of childhood (incidence between 
1:2000 and 1:4000 newborns) (49); however, only a small propor-
tion of CHT cases are attributed to known genetic mutations. Pre-
vious studies in Europe and Asia have found that the incidence of 
CHT displays a seasonal pattern (12, 13), in support of an environ-
mental component in the etiology of CHT. Further characterization 
of environmentally sensitive epigenetic regions (such as PAX8) 
associated with thyroid development could thus have public health 
implications in identifying environmental drivers for CHT. Sexually 
dimorphic methylation effects such as those we observed at PAX8 
[and in a previous Gambian study (29)] may also help to explain the 
preponderance for CHT in females (2:1) (49).
We identified one child from the high methylation group with 
thyroid hemiagenesis, a rare developmental thyroid anomaly (prevalence 
reported to be between 0.05 and 0.5%) that has been associated with 
PAX8 gene mutations (50). While we cannot attribute PAX8 hyper-
methylation as the direct cause of this anomaly, the possible contri-
bution of epigenetic alterations to abnormal thyroid development 
warrants further research.
In this study, we have also demonstrated associations between 
free T4 and body fat and BMD in Gambian children. In common 
with our findings, there is growing evidence that free T4 levels within 
the normal range are inversely correlated with measures of body fat 
(51). Data from Korean children found that free T4 was inversely 
correlated with waist circumference, BMI, and markers of insulin 
resistance (51). A study in U.K. children demonstrated that free T4 
was negatively associated with FMI (from DXA) and BMI. To explore 
the direction of causation, the authors used Mendelian randomization 
and found that while BMI and body fat caused an increase in free 
T3, they did not seem to influence levels of free T4 (5). Thyroid 








































































































Fig. 4. C alleles at rs10193733 are associated with decreased DNA methyla-
tion variation at the PAX8 region of interest. DNA methylation at CpGs is shown 
for the PAX8 region of interest (delimited by red brackets) and flanking 200-bp 
region, split by rs10193733 genotype. Numbers in brackets denote the counts of 
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volume and TSH have been shown to change in response to weight 
loss, although free T4 remains unchanged, further supporting the 
idea that free T4 is not influenced by body composition (52). Data 
from African children are limited, although a positive correlation 
between free T3/T4 ratio and BMI has been reported in Nigerian 
children (53). We found no association between free T4 and mea-
sures of lean mass, although an inverse relationship between free T4 
and lean mass has been reported previously (54).
Free T4 has been reported to be negatively associated with BMD 
in adults (3), and higher free T4 (within the population reference 
range) is associated with an increased incidence of fractures in older 
people (55). Chondrocytes, osteoblasts, and osteoclasts express TSH 
receptor and thyroid hormone receptor, and thus, there is a biological 
target for thyroid hormone to affect bone modeling (56). Our novel 
finding that BMD is associated with free T4 in mid-childhood is of 
great interest as this reflects an important period of bone accrual 
and attainment of peak bone mass, which is related to future frac-
ture risk. We found no overall effect of PAX8 methylation on BMD 
and so did not investigate the possibility that the effect of methyl-
ation on BMD is mediated by free T4. However, it is possible that 
PAX8 methylation may exert countervailing effects on BMD such 
that the net effect is nonsignificant despite their being a significant 
causal pathway between PAX8 methylation, free T4, and BMD. PAX8 
has been reported to be hypomethylated in human cartilage in indi-
viduals with osteoarthritis (57), which is of interest considering our 
finding that low PAX8 methylation is associated with higher free 
T4, which, in turn, is associated with lower BMD.
The associations between PAX8 methylation, thyroid phenotype 
and BMI, fat, and bone measures could reflect an adaptive process. 
For example, if higher PAX8 methylation [associated with a nega-
tive maternal energy balance in the Gambian rainy season (34)] is 
associated with a reduced level of thinness (as shown by a higher 
BMI in the high methylation group), then this could be an example 
of the organism developing greater fat stores in response to a pre-
dicted nutritionally adverse postnatal environment.
We found an inverse relationship between PAX8 methylation 
and PAX8-AS1 expression (measured by RSEM) in normal thyroid 
biopsies using data from the TCGA. However, we obtained contra-
dictory results when PAX-AS1 expression was measured using the 
FPKM metric (both expression measures are provided in the TCGA 
dataset). In general, these metrics are well correlated except when 
the exons are short (as for PAX8-AS1). There may be difficulty in 
accurately assessing the expression with short transcripts due to 
limitations with the sequencing technology and normalization methods 
(58); therefore, we present both metrics for consideration. DNA 
methylation in gene promoters is generally associated with condensed 
heterochromatin and reduced gene expression (22), while methyl-
ation within genes, downstream from the transcription start site (TSS), 
does not have as clear a correlation with gene expression (59). Our 
region of interest is intragenic to PAX8 but is located within a pro-
moter region of the antisense long noncoding RNA (lncRNA) 
PAX8-AS1 (also referred to as LOC654433). At loci such as this, it is 
possible for complex regulatory interactions to exist between DNA 
methylation, coding gene expression, and noncoding RNA expres-
sion (59). A study in fibroblasts demonstrated that the relationship 
between methylation and gene expression at PAX8 is region specif-
ic, with a positive correlation between methylation and expression 
reported at CpGs close to the PAX8 TSS and a strong negative cor-
relation reported at intragenic CpGs located near the PAX8-AS1 
TSS, including one of the CpGs in our region of interest (60). 
Furthermore, this study demonstrated a positive correlation between 
PAX8 and PAX8-AS1 gene expression and postulated a potential 
chromatin-activation linked role of PAX8-AS1 in regulating PAX8 
expression. Previous studies have demonstrated that polymorphisms 
in PAX8-AS1 are potentially expression quantitative trait loci for PAX8 
(61), and therefore, it appears that our region could be a putative 
intragenic regulatory region. The specific biological consequence of 
the PAX8-AS1 lncRNA is still yet to be fully elucidated, but variants 
in PAX8-AS1 are associated with cancer risk (62).
A previous study identified moderate iodine deficiency in Gambian 
children aged 8 to 12 years (63), and mothers recruited for the ENID 
trial whose offspring were followed up for this study were found to 
have moderate iodine deficiency (64). We therefore attempted to 
account for this in our analysis as iodine levels can influence thyroid 
volume and function. We found no difference between the PAX8 
methylation groups when a Tg cutoff was used to define iodine 
insufficiency, but we did find a significant difference between the 
groups when using UIC and therefore adjusted for this in the anal-
ysis. We recognize that a measure of urinary iodine can be a useful 
tool to understand iodine insufficiency in a population but may be 
less useful for characterizing an individual’s iodine status (65). 
However, we note that iodine levels were all taken at the same time 
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Fig. 5. Proposed model linking PAX8 methylation and expression, thyroid function and development, and phenotype. (1) PAX8 methylation is influenced by peri-
conceptional nutritional factors, sex, and genotype. (2) PAX8 methylation is set early in embryonic development. (3) PAX8 methylation sets a trajectory for thyroid gland 
development: PAX8 is expressed from gestational days 20 to 22 in humans, around the same time that thyroid progenitor cells begin specification in the endoderm (15). 
PAX8 methylation state (or related epigenetic factors) alters PAX8 expression that influences thyroid gland development. (4) PAX8 methylation is inversely associated with 
thyroid size and free T4 in mid-childhood. (5) Free T4 is inversely associated with fat and BMD in mid-childhood. (6) PAX8 methylation is inversely associated with PAX8-AS1 
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of year, all in the morning from fasted individuals and where the 
local diet day to day is relatively consistent, suggesting that UIC 
may be informative. It is possible that differential PAX8 methyla-
tion could be contributing to the observed differences in urinary 
iodine between the two groups possibly by influencing expression 
of the sodium-iodide symporter.
Prior evidence that PAX8 methylation is a putative ME, with sys-
temic methylation established in the early embryo, supports the no-
tion that interindividual variation in PAX8 methylation or related 
epigenetic marks may drive the phenotypic differences observed in 
this study. This highlights the potential benefits of studying links 
between regions of systemic interindividual variation and risk of 
disease (66). In this study, we cannot rule out the possibility of a 
reverse causation effect of thyroid function measures on methyla-
tion or other related epigenetic factors at 2 years of age. Elucidation 
of causal pathways linking environmental exposure, methylation 
and other epigenetic factors, gene expression, and postnatal pheno-
type will require mechanistic investigations in cell or animal mod-
els. For example, a mouse model has demonstrated an association 
between high estrogen exposure in early pregnancy and higher free 
T4, PAX8 promoter hypomethylation, and increased PAX8 expres-
sion in offspring (67). However, we note that our region of interest 
is at least partially absent from several species commonly used as 
models of development including mouse, zebrafish, and Xenopus 
tropicalis. Furthermore, the PAX8-AS1 lncRNA present in humans 
does not appear to exist in other species. Its putative role in regulat-
ing PAX8 expression and thyroid development may therefore only 
exist in humans.
In summary, we have demonstrated that individual variation in 
DNA methylation at a region of the PAX8 gene sensitive to pericon-
ceptional nutrition is significantly associated with total thyroid vol-
ume and free T4 levels in Gambian children. Our work has potential 
implications for understanding the fetal origins of health and dis-
ease and may contribute to our understanding of the epigenetic 
drivers of thyroid development and function.
MATERIALS AND METHODS
Experimental design
We used a “recall-by-epigenotype” design to examine links between 
PAX8 DNA methylation measured at 2 years of age and thyroid 
gland function and development in the same Gambian children 
aged 5 to 8 years. We used an existing longitudinal cohort of 
Gambian children [children from the ENID (37) study now aged 
between 5 and 8 years, n = 493] to recruit the top (high) and bottom 
(low) quantiles for DNA methylation at a region of the PAX8 gene 
previously identified as sensitive to the periconceptional environ-
ment from banked DNA at 2 years of age. Participants were assessed 
for thyroid volume, function (free T3, free T4, TSH, and Tg), UIC, 
and body composition and bone measures by whole-body DXA 
scan. Figure 1 provides an overview of the study, and further details 
are provided below.
ENID trial and cohort
The ENID trial (ISRCTN49285450) (37) was a combined trial of 
pregnancy and infancy nutritional supplementation conducted in 
West Kiang, a rural region of The Gambia, recruiting pregnant 
mothers between January 2010 and February 2014. Briefly, women 
were recruited in early pregnancy (10 to 20 weeks) and randomized 
to receive either (i) iron-folate (standard care); (ii) MMN; (iii) ener-
gy, protein, and lipid with iron-folate; or (iv) energy, protein, and 
lipid with MMN supplements for the remainder of their pregnancy. 
There were no differences in maternal (BMI, age, and parity) or in-
fant characteristics (birthweight, birth length, sex, or gestational 
age) across the study arms (68). From 6 to 18 months of age, infants 
were further randomized to a lipid-based nutritional supplement, 
with or without additional MMN. A total of 875 women were ran-
domized in pregnancy to one of the four study arms and 686 partic-
ipants completed follow-up to 2 years of age (69). Routine blood 
samples were collected from mothers and infants at various time 
points including a peripheral blood cell DNA samples stored at age 
2 years. At the time of this current study, children from the ENID 
study, now aged between 5 and 8 years of age (n = 493), were being 
followed up monthly in a separate longitudinal observational study 
(see Fig. 1).
PAX8 methylation measurement at 2 years of age
Children from the original ENID trial had DNA isolated from 
whole blood at age 2 years. DNA was enriched for a panel of candi-
date regions and bisulfite-converted using a custom Agilent SureSelect 
Methyl-Seq targeted capture system on a subset of these children 
with sufficient DNA available for processing (n = 521) (70). Target- 
enriched DNA, including the PAX8 region of interest, was sequenced 
using the Illumina NovaSeq platform at the Human Genome Se-
quencing Center, Baylor College of Medicine, Houston, Texas, 
USA. Reads were mapped to the human genome (hg38) using 
Bismark v0.20.0 (71) with default options, which was also used 
to extract methylation values after mapping. Methylation calls 
from opposite strands of the same CpG site were combined. 
Within each individual, CpG sites were considered “covered” if 
they had a read depth of at least 20×; uncovered sites were ex-
cluded from analyses.
Selection of PAX8 region of interest
We selected a subset of CpGs in the PAX8 region for which there 
was independent evidence of systemic interindividual variation and 
sensitivity to early environment from previous studies (23, 25, 27). 
From these, four CpGs of interest, with coverage in a large number 
of samples and strong correlation with nearby CpGs, were chosen 
(see fig. S10): chr2:113,235,186; chr2:113,235,228; chr2:113,235,251; 
and chr2:113,235,267. All of these CpGs lie in intron 9 of PAX8 and 
in a promoter re gion of antisense PAX8-AS1 (see Fig. 2; all genomic 
coordinates hg38).
Participant selection
From the 493 children being followed up in the ENID cohort at age 
5 to 8 years (see Fig. 1), a “recall by epigenotype” design was used 
whereby participants were selected by methylation level at CpG 
chr2:113,235,228. This CpG was chosen due to it having the best 
overall correlations with nearby CpG methylation levels (see fig. 
S10). Individuals with at least one other informative CpG among 
the four CpGs of interest and without large differences (≥0.2) in 
quantile among the CpGs of interest (n = 217) were then placed into 
high or low groups based on the chr2:113,235,228 methylation level 
(see Fig. 3). In total, 125 participants (low PAX8 methylation group 
n = 64, high PAX8 methylation group n = 61) were identified for 
potential recruitment, with 118 participants (94%) consenting to 
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Thyroid volume assessment
Thyroid ultrasound was conducted by T.C. who was blinded to the 
participant’s PAX8 methylation group. The length (l), width (w), 
and depth (d) of each thyroid lobe (in centimeters) were measured 
on transverse and longitudinal scans using Sonosite MicroMaxx 
(10-Hz probe). All measurements were made in triplicate, and the 
mean was used for analysis. The volume (Vol) of each lobe (in mil-
liliters) was estimated by the modified formula for an ellipsoid; 
Vol(ml) = (0.479 × d × w × l) (72), and the total thyroid volume was 
calculated as the sum of the volumes of both lobes.
Mid-childhood blood collection and biochemical 
assessments
Recruited children had a morning (between 8 a.m. and 10.30 a.m.) 
venous blood sample taken into a serum sample collection tube in 
April 2019. Aliquoted serum was frozen at −70°C. The cellular frac-
tion was discarded. During the same study visit as the blood sample 
and thyroid ultrasound, a fasted morning urine sample was collect-
ed in iodine-free tubes and stored at −20°C. The urine and serum 
samples were shipped to the University Hospital of Wales, UK for 
thyroid hormone and urinary iodine measurements. Serum TSH, 
free T3, and free T4 were measured by the automated ALINITY 
System (Abott Laboratories, USA), and Tg was measured by the 
Beckman Access DxI. Urinary iodine and urinary creatinine were 
measured by inductively coupled plasma mass spectrometry. Iodine 
sufficiency was defined as a Tg < 40 g/liter and/or a UIC > 100 g/
liter (63).
Other phenotypic measures
Standing height was calculated as the mean of measures taken in 
triplicate to the nearest millimeter using a portable stadiometer 
(Seca 213). Weight was similarly calculated from measures in tripli-
cate to the nearest 0.1 kg using electronic scales (Seca 803), with 
participants clothed, but with shoes and coat removed. BMI was 
calculated as weight (kilograms) divided by height2 (m2). HAZ, 
WAZ, and BMI SD score for each participant were calculated using 
World Health Organization reference ranges (73). A whole-body 
DXA scan was performed using the GE-Lunar Prodigy scanner (GE 
Medical, Waltham, MA; software version 13.60.033) on 113 chil-
dren (5 did not attend for DXA scan). Bone-related outputs included 
areal BMD (g/cm2), bone mineral content (BMC, g), and bone area 
(BA, cm2). For children, it is recommended to use TBLH for 
bone-related measurements (74). The analyzed outcome measure 
for bone was TBLH BMD and was calculated as TBLH BMD 
(g/cm3) = TBLH BMC (g)/ TBLH BA (cm2). The analyzed outcome 
measure for body fat was FMI, which was calculated as fat mass (kg) 
divided by height2 (m2). The analyzed outcome measure for lean 
mass was LMI, which was calculated as lean mass (kg) divided by 
height2 (m2).
Maternal biomarker data
Women recruited to the ENID trial provided a 10-ml venous blood 
sample at the time of enrolment in early pregnancy (<20 weeks of 
gestation). Plasma was stored at −70°C. A subset of 350 women 
were previously selected for biomarker analysis on the stored sam-
ples; n  =  303 women with maternal biomarker data had PAX8 
methylation data available for their offspring. These women were 
selected to give an even distribution by month of enrolment and to 
provide data from the earliest gestational age, i.e., sample collection 
nearest to time of conception (median 12.1 weeks, IQR 3.5). In our 
analysis, we examined a core set of 10 nutritional biomarkers in-
volved in one-carbon metabolism [homocysteine, methionine, cys-
teine, choline, betaine, dimethylglycine (DMG), vitamin B12, folate, 
PLP, and vitamin B2 (riboflavin)]. We also considered an extended 
panel of biomarkers to capture other metabolic pathways potential-
ly influencing one-carbon metabolism [alpha-1-acid glycoprotein 
(AGP), aspartate, threonine, serine, glutamate, glycine, alanine, va-
line, isoleucine, leucine, tyrosine, phenylalanine, lysine, histidine, 
arginine, proline, uridine, and uracil]. Biomarkers were analyzed at 
the BC Children’s Hospital, Canada, using liquid chromatography–
tandem mass spectrometry (choline, betaine, DMG, homocysteine, 
cysteine, methionine, PLP, riboflavin, uracil, and uridine), Abbott 
AxSYM autoanalyzer (folate and vitamin B12), and Hitachi L-8900 
amino acid analyzer (additional amino acids: serine, glycine, ala-
nine, arginine, aspartic acid, glutamic acid, histidine, isoleucine, 
leucine, lysine, phenylalanine, proline, threonine, tryptophan, tyro-
sine, and valine). The inflammatory marker AGP was measured 
using the Cobas Integra 400 plus autoanalyzer at the MRC Unit The 
Gambia, Keneba field station.
Stability of PAX8 methylation from mid-childhood to after 
puberty/adolescence
Stability of the four selected PAX8 CpGs with age was assessed by 
analyzing blood samples from 49 Gambians with samples collected 
in mid-childhood (7 years old) and adolescence (17 years old) (25) 
by pyrosequencing (see Supplementary Methods).
PAX8 gene expression and DNA methylation in blood 
and thyroid tissues
We accessed data from TCGA, an open access resource providing 
genomic data for more than 20,000 cancer and noncancerous 
matched samples obtained from biopsy from live individuals. We 
downloaded PAX8 gene expression data on 50 individuals with 
noncancerous thyroid samples, reported as both FPKM upper 
quartile (from GDC v18.0 PANCAN HTSeq hosted by Xena, 
https://gdc.xenahubs.net) and RSEM (data from TCGA Wanderer, 
http://maplab.imppc.org/wanderer/) from Illumina HiSeq RNA-seq 
data. TCGA methylation data for the same samples measured on the 
Illumina HumanMethylation450 array were available for two of our CpGs 
of interest (chr2:113,235,186 and 113,235,267) from TCGA Wanderer.
A comparison of PAX8 methylation levels in blood and thyroid 
tissue was carried out through quantitative analysis of the four 
PAX8 CpGs of interest by bisulfite pyrosequencing in paired thyroid 
tissue, and whole blood samples from 86 donors were obtained from 
the GTEx postmortem tissue database (38) (see Supplementary 
Methods for sample details).
Genotyping from methyl-seq data
We used the targeted methyl sequencing (methyl-seq) data to call 
individual genotypes within the PAX8 gene. A modified version of 
BS-Snper (75, 76) was used to call SNP genotypes from the bisulfite- 
converted reads. Genotypes with a nonreference allele frequency (AF) 
of ≥0.05 and with a call rate (proportion of individuals with called 
genotypes) of 20% or higher were considered for the analysis (n = 14 SNPs). 
Of these, SNP rs10193733 (chr2:113,235,047 T > C; MAF, 0.25) was 
the closest to the PAX8 variably methylated region analyzed here 
(see Fig. 2) and had a high call rate in the methyl-seq dataset (>99% 
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analysis of interactions between methylation, genotype, and thyroid 
phenotypes. Furthermore, we verified that this SNP is in LD with 
several other SNPs on either side of the variably methylated region 
using Gambian reference data from the Gambian Genome Variation 
Project (GGVP) (77) and 1000 Genomes Project, Phase3 [Gambia 
West Division (GWD)] (78) and confirmed this in our study popu-
lation (see fig. S11). This SNP and the nearby SNPs in LD all had 
similar AFs to the GWD reference population from GGVP, demon-
strating the reliability of the methyl-seq–derived genotypes (with 
the exception of rs7576384 chr2:113235808 C > G, which had a much 
lower AF than expected, likely due to the loss of informative reads 
after bisulfite conversion). A 2–base pair (bp) indel polymorphism 
not detectable by the genotype caller, rs35724515 (chr2:113235224 
CCC > C), is located within our region of interest and is in high LD 
with rs10193733 (1000 Genomes GWD LD r2 = 0.976).
Statistical analysis
Baseline characteristics and crude between-group comparisons
Differences between high and low PAX8 methylation groups for the 
categorical variables of sex, pregnancy and infant supplementation, 
and iodine sufficiency (yes/no) were assessed using Pearson chi-
square tests. Birth weight, WAZ, BMI z score, HAZ, total thyroid 
volume, free T4, and free T3 were normally distributed, and group 
differences were assessed using Student’s t test with mean and SD 
reported. Age, UIC, urinary iodine:creatinine ratio, TSH, and Tg 
were not normally distributed, and group differences were assessed 
by Mann-Whitney U tests with median and IQR reported.
Multiple linear regression models
Unless otherwise indicated, all outcome variables were normally 
distributed.
Thyroid volume . Thyroid volume as the dependent variable was 
regressed against PAX8 methylation group and adjusted for sex, 
age, BMI, and UIC. BMI was included to ensure an adjustment for 
body size as (i) there was a significant difference between the two 
groups at recruitment and (ii) BMI also provided the best model fit 
(indicated by lowest Akaike information criterion) compared to 
other measures of body size (e.g., WAZ, HAZ, and body surface 
area). UIC was included as there was a significant difference be-
tween the groups at recruitment and iodine deficiency can be asso-
ciated with goiter/thyroid size.
Measures of thyroid function. Measures of thyroid function (free 
T4, free T3, TSH, and Tg) were regressed against PAX8 methylation 
group and adjusted for sex, age, and UIC. TSH and Tg were nor-
mally distributed after log transformation before regression analy-
sis. Iodine deficiency can be associated with hypothyroidism and an 
increase in Tg, and therefore, UIC was included in all models. Cor-
rection for multiple tests was not made as the markers of thyroid 
function are not independent.
DXA-derived measures. FMI was normally distributed after log 
transformation. FMI was regressed against free T4 and adjusted for 
age, sex, and weight (to adjust for lean mass). LMI was regressed 
against free T4, with LMI adjusted for age, sex, and weight (to adjust 
for fat mass). TBLH BMD was normally distributed after log trans-
formation and regressed against free T4, adjusted for age, sex, 
weight, and height.
Predictors of PAX8 methylation analysis
In analyses where PAX8 methylation was considered as an out-
come, 2-year methylation measurements were taken from the wider 
ENID cohort (i.e., not just the high and low PAX8 methylation 
groups; n = 303 to 521 depending on the predictor considered) and 
treated as a continuous variable. Methylation across the four CpGs 
of interest was highly correlated (Pearson R between 0.871 and 
0.952; fig. S10). A univariate composite measure was therefore used 
in all regression models, calculated as the mean z score (over all 
CpG sites) of the logit-transformed methylation level at each CpG 
site (referred to as PAX8 mean logit methylation z score). Methyla-
tion levels of 1.0 were reduced to 0.99 to prevent infinite values after 
logit transformation.
All maternal biomarkers were preadjusted for gestational age, 
maternal BMI, maternal age, and inflammation (AGP) and then 
back-extrapolated to date of conception using previously described 
methods (29). Those biomarkers not normally distributed were 
log-transformed, and all biomarkers were scaled and centered to 
enable comparison of standardized coefficients. Multiple linear re-
gression models with PAX8 mean logit methylation z score as the 
dependent variable were fitted individually with each biomarker as 
a predictor and adjusted for sex.
For other predictors, PAX8 mean logit methylation z score was 
regressed against maternal BMI, infant BMI z score, infant WAZ, 
infant sex, and SoC in separate models. SoC was defined as “rainy” 
(January to June) and “dry” (July to December) as previously de-
scribed (79) with the conception date calculated from a gestational 
age estimation obtained from antenatal ultrasound at ENID trial 
recruitment.
All model covariates were assessed for multicollinearity, and 
standard tests were performed to ensure that linear modeling as-
sumptions were met. Where reported, coefficients () associated 
with log-transformed dependent variables were back transformed 
using (exp() − 1) × 100 to represent percentage change in depen-
dent variable per unit increase in the corresponding predictor.
Causal mediation analysis
We performed a causal mediation analysis to test the hypothesis 
that the observed effect of PAX8 methylation group on free T4 is 
mediated by its effect on thyroid volume. We used the Mediation 
package (v4.5.0) in R, with confidence intervals for direct and indi-
rect effects calculated using a nonparametric bootstrap with 10,000 
simulations. All statistical analyses were performed using R version 
3.6.2 (80).
Analyses by genotype
Genetic analyses focused on a single SNP (rs10193733) that tagged 
an LD block proximal to our PAX8 region of interest (see above for 
justification for choosing this SNP). We performed two sets of anal-
yses stratified by rs10193733 genotype. First, Student’s t tests were 
used to compare the PAX8 mean logit methylation z score between 
SoC (rainy versus dry) separately for individuals with each geno-
type. Second, we fitted multiple linear regression models with total 
thyroid volume and free T4 as dependent variables adjusted for rel-
evant covariables, again stratified by rs10193733 genotype. We also 
assessed the influence of the rs10193733 “C” allele on free T4 and 
thyroid volume (outcome variables) in multiple regression models 
with allelic dosage (predictor) coded as C/C = 2, C/T = 1, T/T = 0.
Ethics
Ethical approvals for the ENID trial and for this study were given by 
The Gambia Government/MRC Joint Ethics Committee (SCC1126v2, 
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thumb print from mothers for their own participation and that of 
their child. All data were anonymized before analysis.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at https://science.org/doi/10.1126/
sciadv.abj1561
View/request a protocol for this paper from Bio-protocol.
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